Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04784247
Title Lenvatinib and Pembrolizumab in People With Advanced Soft Tissue Sarcoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Memorial Sloan Kettering Cancer Center
Indications

leiomyosarcoma

malignant epithelioid hemangioendothelioma

bone sarcoma

osteosarcoma

malignant peripheral nerve sheath tumor

angiosarcoma

sarcoma

chondrosarcoma

synovial sarcoma

Therapies

Lenvatinib + Pembrolizumab

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.